RE:RE:RE:RE:RE:RE:Bored. Waiting. Here is some playing with data to look at. 99942Apophis wrote: I see we once again are using the "cure word" although its far too early for that title, perhaps continued CR durability can be more accurate until a greater time frame can back it up. Yes 40% is what we can be expected as a ok threshold for now however I believe most of us can hope for a strong possibility of reaching 55% or better for the final outcome. Honestly I've had a difficult time accepting anything below 85% only because in theory Ruvidar should work extremely well in the destruction of Cancer. At least the company is learning much about their fight for other indications through the first of many battles with that horrible disease.
Agreed
Still I haven't seem CR durability with this molecule in reports thus far-the phase 1 didnt reports and the recent phase IIb 40%CR was less than a year, and a interim analysis without full reporting of the data or imputation reported-certainly not durable from a clinicians or patients perspective, Perhaps Eon or others can provide a link to an RCT showing this
Will be delighted to read data supporting the post